Keyphrases
Glucagon-like
100%
Obstructive Lung Disease
100%
Lung Function
100%
Female Mice
100%
GLP-1 Receptor Agonist
83%
Surfactant
33%
Glucagon-like peptide-1 Receptor (GLP-1R)
33%
Ovalbumin
33%
Therapeutic Potential
16%
Inhalation
16%
Release Effect
16%
Acute Exacerbation
16%
Receptor Agonist
16%
Inflammatory Markers
16%
Agonist Treatment
16%
A1 Receptor
16%
Type 2 Diabetes Prevention
16%
Potential Therapeutics
16%
Clinical Appearance
16%
Mechanism of Action
16%
Survival Rate
16%
Pulmonary Function
16%
Chronic Obstructive Pulmonary Disease
16%
Mouse Model
16%
Lipopolysaccharide
16%
Incretin Hormones
16%
Lung Tissue
16%
Inflammatory Cytokines
16%
MRNA Level
16%
Inflammation
16%
Insulin Secretagogue
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Glucagon Like Peptide 1 Receptor Agonist
100%
Glucagon-Like Peptide-1
100%
Ovalbumin
33%
Surfactant
33%
Glucagon-Like Peptide 1 Receptor
33%
Inflammation
16%
Lipopolysaccharide
16%
Incretin
16%
Messenger RNA
16%
Non Insulin Dependent Diabetes Mellitus
16%
Mouse Model
16%
Cytokine
16%